Epigral Ltd. (EPIGRAL) - Total Liabilities

Latest as of March 2026: Rs12.84 Billion INR ≈ $138.85 Million USD

Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has total liabilities worth Rs12.84 Billion INR (≈ $138.85 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Epigral Ltd. - Total Liabilities Trend (2015–2026)

This chart illustrates how Epigral Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See EPIGRAL current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Epigral Ltd. Competitors by Total Liabilities

The table below lists competitors of Epigral Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Solus Advanced Materials Co Ltd KO:336370	Korea	₩1.08 Trillion
Neuropace Inc NASDAQ:NPCE	USA	$84.44 Million
Wuxi Jinyang New Materials Co. Ltd. A SHE:301210	China	CN¥1.31 Billion
Societe de la Tour Eiffel SA PA:EIFF	France	€541.80 Million
Beijing Hualian Department Store Co Ltd SHE:000882	China	CN¥5.56 Billion
Shanghai Yahong Moulding Co Ltd SHG:603159	China	CN¥86.94 Million
Jiangsu United Water Technology Co. Ltd. Cl A SHG:603291	China	CN¥1.99 Billion
Invesco Quality Municipal Income Closed Fund NYSE:IQI	USA	$297.67 Million

Liability Composition Analysis (2015–2026)

This chart breaks down Epigral Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EPIGRAL market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.16	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.58	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Epigral Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Epigral Ltd. (2015–2026)

The table below shows the annual total liabilities of Epigral Ltd. from 2015 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs12.84 Billion ≈ $138.85 Million	+2.88%
2025-03-31	Rs12.48 Billion ≈ $134.96 Million	-18.98%
2024-03-31	Rs15.40 Billion ≈ $166.57 Million	+12.99%
2023-03-31	Rs13.63 Billion ≈ $147.42 Million	-2.47%
2022-03-31	Rs13.98 Billion ≈ $151.16 Million	+82.81%
2021-03-31	Rs7.65 Billion ≈ $82.69 Million	+10.81%
2020-03-31	Rs6.90 Billion ≈ $74.62 Million	+25.12%
2019-03-31	Rs5.51 Billion ≈ $59.64 Million	+259.21%
2018-03-31	Rs1.54 Billion ≈ $16.60 Million	-7.43%
2017-03-31	Rs1.66 Billion ≈ $17.93 Million	-32.24%
2016-03-31	Rs2.45 Billion ≈ $26.47 Million	-22.05%
2015-03-31	Rs3.14 Billion ≈ $33.96 Million	--

About Epigral Ltd.

NSE:EPIGRAL India Chemicals

Market Cap

$532.76 Million

Rs49.26 Billion INR

Market Cap Rank

#12046 Global

#587 in India

Share Price

Rs1141.90

Change (1 day)

+0.96%

52-Week Range

Rs810.45 - Rs2088.70

All Time High

Rs2344.35